Sam Chun Dang Pharm Dividends and Buybacks
Dividend criteria checks 0/6
Sam Chun Dang Pharm is a dividend paying company with a current yield of 0.14%.
Key information
0.1%
Dividend yield
-2.1%
Buyback Yield
| Total Shareholder Yield | -1.9% |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | -42% |
Recent dividend and buyback updates
No updates
Recent updates
Risks Still Elevated At These Prices As Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250) Shares Dive 26%
Apr 22
We Think Sam Chun Dang Pharm (KOSDAQ:000250) Is Taking Some Risk With Its Debt
Mar 27Revenues Not Telling The Story For Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250) After Shares Rise 29%
Feb 05Here's Why Sam Chun Dang Pharm (KOSDAQ:000250) Has A Meaningful Debt Burden
Dec 22Risks Still Elevated At These Prices As Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250) Shares Dive 26%
Nov 30Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250) Investors Are Less Pessimistic Than Expected
Oct 05Sam Chun Dang Pharm (KOSDAQ:000250) Takes On Some Risk With Its Use Of Debt
Sep 08Subdued Growth No Barrier To Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250) With Shares Advancing 44%
Jun 19Is Sam Chun Dang Pharm (KOSDAQ:000250) A Risky Investment?
Jun 09Optimistic Investors Push Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250) Shares Up 28% But Growth Is Lacking
Mar 21Sam Chun Dang Pharm (KOSDAQ:000250) Seems To Use Debt Quite Sensibly
Feb 26Investors Who Bought Sam Chun Dang Pharm (KOSDAQ:000250) Shares Five Years Ago Are Now Up 644%
Feb 09Could The Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250) Ownership Structure Tell Us Something Useful?
Jan 05
Here's Why Sam Chun Dang Pharm (KOSDAQ:000250) Can Manage Its Debt Responsibly
Dec 01Stability and Growth of Payments
Fetching dividends data
Stable Dividend: A000250 is not paying a notable dividend for the KR market, therefore no need to check if payments are stable.
Growing Dividend: A000250 is not paying a notable dividend for the KR market, therefore no need to check if payments are increasing.
Dividend Yield vs Market
| Sam Chun Dang Pharm Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (A000250) | 0.1% |
| Market Bottom 25% (KR) | 1.2% |
| Market Top 25% (KR) | 3.9% |
| Industry Average (Pharmaceuticals) | 1.1% |
| Analyst forecast (A000250) (up to 3 years) | n/a |
Notable Dividend: A000250's dividend (0.14%) isn’t notable compared to the bottom 25% of dividend payers in the KR market (1.2%).
High Dividend: A000250's dividend (0.14%) is low compared to the top 25% of dividend payers in the KR market (3.88%).
Earnings Payout to Shareholders
Earnings Coverage: A000250 is not paying a notable dividend for the KR market.
Cash Payout to Shareholders
Cash Flow Coverage: A000250 is paying a dividend but the company has no free cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/18 21:24 |
| End of Day Share Price | 2025/05/16 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Sam Chun Dang Pharm. Co., Ltd is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hyung Soo Kim | Cape Investment & Securities Co., Ltd. |
| Al Eum Lee | iM Securities |
| Hong-Sik Jeong | LS Securities Co., Ltd. |